- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01477216
Determination of Glycemic and Insulinemic Indices (ELSA)
November 18, 2011 updated by: Finnish Institute for Health and Welfare
The Glycemic and Insulinemic Responses of the Finnish Foods: Measurement and Modification
The aim of this study to investigate methodological aspects that may affect glycemic index (GI) and insulinemic (II) values. In addition, we will measure GI and II values for typical Finnish carbohydrate-rich foods and provide a database of GIs for Finnish foods.
The specific aims of this study are:
- to compare glycemic responses and GIs analyzed from capillary and venous blood to compare glucose against white bread as the reference food, and to study the effect of number of reference tests on GI values. For each setting of the tested parameters, we determined the glycemic indices of rye bread, oatmeal porridge and instant mashed potato
- to examine the glycaemic and insulinaemic responses of a mashed potato-based meal when a high fat food (rapeseed oil) or a high protein food (chicken breast) or fat, protein and salad together were added to the meal. Furthermore, we studied how the predicted and measured GI values of the mixed meal differed from each other.
- to examine the effects of two different coffee portions with glucose and caffeine-containing soft drinks on postprandial glucose and insulin responses. Further objectives were to study how coffee and different accompaniments affect glucose and insulin responses.
- to measure GI values for typical Finnish foods
- to study the effects of berries on glycemic and insulinemic responses
- to examine the effects of overweight and glucose tolerance on the glucose, insulin and lipid responses to an HGI meal and an LGI meal.Furthermore, the second aim was to study the effect of BMI and glucose tolerance on the GI measured.
- to compare methodological choices in insulin measurement
- to investigate the effect of alcohol on postprandial glucose and insulin responses, and to determine glycemic and insulinemic indices values for beer and non-alcoholic beer
Study Overview
Study Type
Interventional
Enrollment (Actual)
142
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 72 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- For Studies 1-9 a total of 12 to 24 volunteers per study with a normal glucose tolerance based upon a 2 h 75g oral glucose tolerance test (OGTT).
- For Study 7 a total of 24 volunteers with impaired glucose tolerance based on an OGTT.
- For Studies 1-6 and 8-9 with an age of 20 to 60 and with a BMI of 18 to 30 kg/m2.
- For Study 7 an age of 62 to 72 and with a BMI of 20 to 35 kg/m2.
Exclusion Criteria:
- First-degree family history of diabetes
- An active gastrointestinal or metabolic disease
- For Studies 1-6 and 8-9 chronic medication (oral contraceptives were allowed)
- For Study 7 regular medication that would have affect glucose and lipid metabolism
- Smoking
- Pregnancy
- Breastfeeding
- History of polycystic ovary syndrome
- History of gestational diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Measuring method
To compare glycemic responses and GI values from capillary and venous blood and to compare glucose solution with white bread as the reference food and to study the effect of the number of reference tests on GI values.
|
Measuring GI and II values for Finnish foods
|
Experimental: Mixed meals
To examine the glycaemic and insulinaemic responses of a mashed potato-based meal when a high fat food (rapeseed oil) or a high protein food (chicken breast) or fat, protein and salad together were added to the meal.
Furthermore, we studied how the predicted and measured GI values of the mixed meal differed from each other.
|
Measuring GI and II values for Finnish foods
|
Experimental: Coffee
To examine the effects of two different coffee portions with glucose and caffeine-containing soft drinks on postprandial glucose and insulin responses.
Further objectives were to study how coffee and different accompaniments affect glucose and insulin responses.
|
Measuring GI and II values for Finnish foods
|
Experimental: Snacks
To measure GI and II values for Finnish snack foods
|
Measuring GI and II values for Finnish foods
|
Experimental: Berries
To study the effects of berries on glycemic and insulinemic responses
|
Measuring GI and II values for Finnish foods
|
Experimental: GIs of low-carbs
To measure glycemic and insulinemic responses to low-carbohydrates foods
|
Measuring GI and II values for Finnish foods
|
Experimental: Glucose metabolism and BMI
To examine the effects of overweight and glucose tolerance on the glucose, insulin and lipid responses to an HGI meal and an LGI meal.
Furthermore, the second aim was to study the effect of BMI and glucose tolerance on the GI measured.
|
Measuring GI and II values for Finnish foods
|
Experimental: Insulin measurement
To compare how methodological choices affect measured insulin values
|
Measuring GI and II values for Finnish foods
|
Experimental: Alcohol
To investigate the effect of alcohol on postprandial glucose and insulin responses, and to determine glycemic and insulinemic indices values for beer and non-alcoholic beer.
|
Measuring GI and II values for Finnish foods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glucose
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Insulin
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Free fatty acids
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Triglyserides
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IGF1
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Satiety
Time Frame: 2 to 5 hours
|
Satiety scores on the satiety scale
|
2 to 5 hours
|
IGF-BP1
Time Frame: 2 to 5 hours
|
Area under the plasma concentration versus time curve (AUC) of food
|
2 to 5 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Liisa M Valsta, DSc, National Institute for Health and Welfare, Helsinki, Finland
- Principal Investigator: Katja A Hätönen, National Institute for Health and Welfare, Helsinki, Finland
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2003
Primary Completion (Actual)
December 1, 2008
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
October 4, 2011
First Submitted That Met QC Criteria
November 18, 2011
First Posted (Estimate)
November 22, 2011
Study Record Updates
Last Update Posted (Estimate)
November 22, 2011
Last Update Submitted That Met QC Criteria
November 18, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TUSU 182-5
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Lipid MetabolismNetherlands
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Wageningen UniversityCompletedGlucose Metabolism | Postprandial Glucose ResponsesNetherlands
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
University of JenaCompletedGlucose Metabolism | Lipid Metabolism | SatietyGermany
-
Charite University, Berlin, GermanyUnknownGlucose Metabolism | Satiety | Endocrine MetabolismGermany
-
University of OuluCompletedGlucose MetabolismFinland
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompleted
-
University of CopenhagenCompletedGlucose Metabolism
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
Clinical Trials on ELSA 1-9
-
University of WashingtonCompletedStress, Psychological
-
Universitas AirlanggaCompletedCOVID-19 | Extracellular Matrix Alteration | Pulmonary InfectionIndonesia
-
London School of Hygiene and Tropical MedicineMerck Sharp & Dohme LLC; Public Health England; University of CambridgeActive, not recruitingHuman Papillomavirus VaccineGambia
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Merck Sharp & Dohme LLCCompletedHyperglycemiaGermany
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); University of MinnesotaCompletedCigarette SmokingUnited States
-
Arisan Therapeutics, Inc.United States Department of Defense; Battelle Memorial Institute; The Defense...RecruitingLassa Virus InfectionUnited States
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
National Cancer Institute (NCI)Completed